Hepatopulmonary syndrome: Difference between revisions
No edit summary Tag: Manual revert |
CSV import |
||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = Hepatopulmonary syndrome | |||
| synonyms = HPS | |||
| field = [[Gastroenterology]], [[Pulmonology]] | |||
| symptoms = [[Shortness of breath]], [[cyanosis]], [[clubbing (medicine)|clubbing]], [[platypnea]], [[orthodeoxia]] | |||
| complications = [[Hypoxemia]], [[respiratory failure]] | |||
| onset = Typically in patients with [[chronic liver disease]] | |||
| duration = Chronic | |||
| causes = [[Liver cirrhosis]], [[portal hypertension]] | |||
| risks = [[Liver disease]], [[alcoholism]], [[hepatitis]] | |||
| diagnosis = [[Contrast-enhanced echocardiography]], [[arterial blood gas]], [[lung perfusion scan]] | |||
| differential = [[Portopulmonary hypertension]], [[chronic obstructive pulmonary disease]], [[interstitial lung disease]] | |||
| treatment = [[Oxygen therapy]], [[liver transplantation]] | |||
| prognosis = Variable, depends on severity and treatment | |||
| frequency = Occurs in 15-20% of patients with [[cirrhosis]] | |||
}} | |||
'''Hepatopulmonary syndrome''' (HPS) is a medical condition characterized by the triad of liver disease, arterial deoxygenation, and intrapulmonary vascular dilatations. It is a significant complication of [[cirrhosis]] and other forms of [[chronic liver disease]]. | '''Hepatopulmonary syndrome''' (HPS) is a medical condition characterized by the triad of liver disease, arterial deoxygenation, and intrapulmonary vascular dilatations. It is a significant complication of [[cirrhosis]] and other forms of [[chronic liver disease]]. | ||
== Pathophysiology == | == Pathophysiology == | ||
Hepatopulmonary syndrome occurs due to the dilation of blood vessels in the lungs, which leads to abnormal oxygen exchange. The exact mechanism is not fully understood, but it is believed to involve increased production of [[nitric oxide]] and other vasodilators in the setting of liver disease. This results in the formation of microscopic intrapulmonary arteriovenous shunts, which impair oxygenation. | Hepatopulmonary syndrome occurs due to the dilation of blood vessels in the lungs, which leads to abnormal oxygen exchange. The exact mechanism is not fully understood, but it is believed to involve increased production of [[nitric oxide]] and other vasodilators in the setting of liver disease. This results in the formation of microscopic intrapulmonary arteriovenous shunts, which impair oxygenation. | ||
== Clinical Features == | == Clinical Features == | ||
Patients with hepatopulmonary syndrome typically present with symptoms of [[dyspnea]] (shortness of breath), [[platypnea]] (worsening of dyspnea when upright), and [[orthodeoxia]] (decrease in arterial oxygenation when upright). Other symptoms may include [[cyanosis]], [[clubbing (medicine)|clubbing]] of the fingers, and signs of chronic liver disease such as [[jaundice]], [[ascites]], and [[spider angiomas]]. | Patients with hepatopulmonary syndrome typically present with symptoms of [[dyspnea]] (shortness of breath), [[platypnea]] (worsening of dyspnea when upright), and [[orthodeoxia]] (decrease in arterial oxygenation when upright). Other symptoms may include [[cyanosis]], [[clubbing (medicine)|clubbing]] of the fingers, and signs of chronic liver disease such as [[jaundice]], [[ascites]], and [[spider angiomas]]. | ||
== Diagnosis == | == Diagnosis == | ||
The diagnosis of hepatopulmonary syndrome is based on the presence of liver disease, arterial deoxygenation, and evidence of intrapulmonary vascular dilatations. Diagnostic tests include: | The diagnosis of hepatopulmonary syndrome is based on the presence of liver disease, arterial deoxygenation, and evidence of intrapulmonary vascular dilatations. Diagnostic tests include: | ||
| Line 12: | Line 26: | ||
* [[Contrast-enhanced echocardiography]] to detect intrapulmonary shunting. | * [[Contrast-enhanced echocardiography]] to detect intrapulmonary shunting. | ||
* [[Lung perfusion scan]] using [[technetium-99m]]-labeled macroaggregated albumin. | * [[Lung perfusion scan]] using [[technetium-99m]]-labeled macroaggregated albumin. | ||
== Treatment == | == Treatment == | ||
There is no specific treatment for hepatopulmonary syndrome, and management primarily focuses on treating the underlying liver disease. [[Liver transplantation]] is the only definitive treatment and can lead to significant improvement or resolution of the syndrome. Supportive measures include oxygen therapy and management of complications related to liver disease. | There is no specific treatment for hepatopulmonary syndrome, and management primarily focuses on treating the underlying liver disease. [[Liver transplantation]] is the only definitive treatment and can lead to significant improvement or resolution of the syndrome. Supportive measures include oxygen therapy and management of complications related to liver disease. | ||
== Prognosis == | == Prognosis == | ||
The prognosis of hepatopulmonary syndrome varies depending on the severity of liver disease and the degree of hypoxemia. Patients with severe hypoxemia have a poorer prognosis. Liver transplantation can significantly improve outcomes in selected patients. | The prognosis of hepatopulmonary syndrome varies depending on the severity of liver disease and the degree of hypoxemia. Patients with severe hypoxemia have a poorer prognosis. Liver transplantation can significantly improve outcomes in selected patients. | ||
== See Also == | == See Also == | ||
* [[Cirrhosis]] | * [[Cirrhosis]] | ||
| Line 25: | Line 36: | ||
* [[Dyspnea]] | * [[Dyspnea]] | ||
* [[Nitric oxide]] | * [[Nitric oxide]] | ||
== References == | == References == | ||
{{Reflist}} | {{Reflist}} | ||
== External Links == | == External Links == | ||
{{Commons category|Hepatopulmonary syndrome}} | {{Commons category|Hepatopulmonary syndrome}} | ||
[[Category:Hepatology]] | [[Category:Hepatology]] | ||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
| Line 37: | Line 45: | ||
[[Category:Respiratory diseases]] | [[Category:Respiratory diseases]] | ||
[[Category:Vascular diseases]] | [[Category:Vascular diseases]] | ||
{{disease-stub}} | {{disease-stub}} | ||
{{No image}} | {{No image}} | ||
Latest revision as of 00:02, 4 April 2025
| Hepatopulmonary syndrome | |
|---|---|
| Synonyms | HPS |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Shortness of breath, cyanosis, clubbing, platypnea, orthodeoxia |
| Complications | Hypoxemia, respiratory failure |
| Onset | Typically in patients with chronic liver disease |
| Duration | Chronic |
| Types | N/A |
| Causes | Liver cirrhosis, portal hypertension |
| Risks | Liver disease, alcoholism, hepatitis |
| Diagnosis | Contrast-enhanced echocardiography, arterial blood gas, lung perfusion scan |
| Differential diagnosis | Portopulmonary hypertension, chronic obstructive pulmonary disease, interstitial lung disease |
| Prevention | N/A |
| Treatment | Oxygen therapy, liver transplantation |
| Medication | N/A |
| Prognosis | Variable, depends on severity and treatment |
| Frequency | Occurs in 15-20% of patients with cirrhosis |
| Deaths | N/A |
Hepatopulmonary syndrome (HPS) is a medical condition characterized by the triad of liver disease, arterial deoxygenation, and intrapulmonary vascular dilatations. It is a significant complication of cirrhosis and other forms of chronic liver disease.
Pathophysiology[edit]
Hepatopulmonary syndrome occurs due to the dilation of blood vessels in the lungs, which leads to abnormal oxygen exchange. The exact mechanism is not fully understood, but it is believed to involve increased production of nitric oxide and other vasodilators in the setting of liver disease. This results in the formation of microscopic intrapulmonary arteriovenous shunts, which impair oxygenation.
Clinical Features[edit]
Patients with hepatopulmonary syndrome typically present with symptoms of dyspnea (shortness of breath), platypnea (worsening of dyspnea when upright), and orthodeoxia (decrease in arterial oxygenation when upright). Other symptoms may include cyanosis, clubbing of the fingers, and signs of chronic liver disease such as jaundice, ascites, and spider angiomas.
Diagnosis[edit]
The diagnosis of hepatopulmonary syndrome is based on the presence of liver disease, arterial deoxygenation, and evidence of intrapulmonary vascular dilatations. Diagnostic tests include:
- Pulse oximetry and arterial blood gas analysis to assess oxygenation.
- Contrast-enhanced echocardiography to detect intrapulmonary shunting.
- Lung perfusion scan using technetium-99m-labeled macroaggregated albumin.
Treatment[edit]
There is no specific treatment for hepatopulmonary syndrome, and management primarily focuses on treating the underlying liver disease. Liver transplantation is the only definitive treatment and can lead to significant improvement or resolution of the syndrome. Supportive measures include oxygen therapy and management of complications related to liver disease.
Prognosis[edit]
The prognosis of hepatopulmonary syndrome varies depending on the severity of liver disease and the degree of hypoxemia. Patients with severe hypoxemia have a poorer prognosis. Liver transplantation can significantly improve outcomes in selected patients.
See Also[edit]
References[edit]
<references group="" responsive="1"></references>
External Links[edit]
